Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Day

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Current Stem Cell Reports|October 5, 2021
Regulatory Framework for Academic Investigator-Sponsored Investigational New Drug Development of Cell and Gene Therapies in the USAAnindya Dasgupta, Kristen Herzegh, H Trent Spencer, et al.
Journal of Pharmaceutical Sciences|November 6, 2022
Predicting Formulation Conditions During Ultrafiltration and Dilution to Drug Substance Using a Donnan Model with Homology-Model Based Protein ChargeAadithya Kannan, Michael Chinn, Saeed Izadi, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 11, 2019
Phase I/II Manufacture of Lentiviral Vectors Under GMP in an Academic SettingAnindya Dasgupta, Stuart Tinch, Kathleen Szczur, et al.
Protein Engineering, Design & Selection : PEDS|December 17, 2008
An antibody loop replacement design feasibility study and a loop-swapped dimer structureLouis A Clark, P Ann Boriack-Sjodin, Eric Day, et al.
The Journal of Biological Chemistry|June 11, 2003
Comparison of soluble decoy IgG fusion proteins of BAFF-R and BCMA as antagonists for BAFFMarc Pelletier, Jeffrey S Thompson, Fang Qian, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Current Stem Cell Reports|October 5, 2021
Regulatory Framework for Academic Investigator-Sponsored Investigational New Drug Development of Cell and Gene Therapies in the USAAnindya Dasgupta, Kristen Herzegh, H Trent Spencer, et al.
Journal of Pharmaceutical Sciences|November 6, 2022
Predicting Formulation Conditions During Ultrafiltration and Dilution to Drug Substance Using a Donnan Model with Homology-Model Based Protein ChargeAadithya Kannan, Michael Chinn, Saeed Izadi, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 11, 2019
Phase I/II Manufacture of Lentiviral Vectors Under GMP in an Academic SettingAnindya Dasgupta, Stuart Tinch, Kathleen Szczur, et al.
Protein Engineering, Design & Selection : PEDS|December 17, 2008
An antibody loop replacement design feasibility study and a loop-swapped dimer structureLouis A Clark, P Ann Boriack-Sjodin, Eric Day, et al.
The Journal of Biological Chemistry|June 11, 2003
Comparison of soluble decoy IgG fusion proteins of BAFF-R and BCMA as antagonists for BAFFMarc Pelletier, Jeffrey S Thompson, Fang Qian, et al.
Pageof 1